(Q35569458)

8 August 2017

1 reference

title

Trials of arsenic trioxide in multiple myeloma (English)

1 reference

8 August 2017

Trials of Arsenic Trioxide in Multiple Myeloma (English)

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

25 March 2024

0 references

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

25 March 2024

author name string

Mohamad A. Hussein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14581891

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14581891

25 March 2024

publication date

1 September 2003

1 reference

8 August 2017

1 reference

8 August 2017

volume

10

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

370-374

1 reference

Nontraditional cytotoxic therapies for relapsed/refractory multiple myeloma

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

Arsenic trioxide: a new immunomodulatory agent in the management of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

Arsenic trioxide: an emerging therapy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

Clinical activity of arsenic trioxide for the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000503

Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As(2)O(3)) on myeloma cells

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

Mechanisms involved in sodium arsenite-induced apoptosis of human neutrophils

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

25 March 2024

13

59

1041

Rousselot P.

1999

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

25 March 2024

14

60

3065

Park W.H.

2000

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

Co-biomodulation with arsenic trioxide in multiple myeloma

25 March 2024

15

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

25 March 2024

17

59

6033

Lew Y.S.

1999

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism

25 March 2024

21

1 reference

https://api.crossref.org/works/10.1177/107327480301000503

25 March 2024

Identifiers

0 references

1 reference